Galway, Ireland, August 6 – AOTI announced today the release of its new Single Use Extremity Chamber and associated controller.
“AOTI continues to listen to our customers and make enhancements to our products”, stated Mike Griffiths President and CEO, “our new Single Use Extremity Chamber offers physicians the flexibility to chose which product best suits their patient needs, while ensuring the therapy remains cost effective.”
Griffiths also added “The new Single Use Chamber provide the same therapeutic benefits, but are easier to use for patients having limited mobility ensuring better compliance with prescribed therapy.”
AOTI is founded on a decade of experience in providing innovative solutions to resolve severe and chronic wounds worldwide. Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses. Our patented non-invasive Topical Wound Oxygen (two2) therapy is unsurpassed in fully closings Diabetic, Venous and Pressure ulcers alike. AOTI is a private company based in Galway, Ireland with offices throughout the globe. For more information, see www.aotinc.net.